Reducing the number of on-the-job opioid deaths is the goal of of workplace safety advocates and industry groups that want businesses to include an overdose prevention drug—Naloxone—in their first aid supplies.
A significant roadblock to employers stocking Naloxone was lifted this year as the Food and Drug Administration approved two nasal spray versions of Naloxone—Narcan and RiVive—as non-prescription drugs that can be sold in stores or online.
“Whether as part of a first aid kit or elsewhere, Naloxone serves as another tool in the toolkit to help keep workers safe,” Lorraine Martin, president of the National Safety Council, said. ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.